Targeted proteomics for quantification of histone acetylation in Alzheimer's disease

Kangling Zhang, Matthew Schrag, Andrew Crofton, Rishi Trivedi, Harry Vinters, Wolff Kirsch

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The epigenetic remodeling of chromatin histone proteins by acetylation has been the subject of recent investigations searching for biomarkers indicative of late onset cognitive loss. Histone acetylations affect the regulation of gene transcription, and the loss of learning induced deacetylation at specific histone sites may represent biomarkers for memory loss and Alzheimer's disease (AD). Selected-reaction-monitoring (SRM) has recently been advanced to quantitate peptides and proteins in complex biological systems. In this paper, we provide evidence that SRM-based targeted proteomics can reliably quantify specific histone acetylations in both AD and control brain by identifying the patterns of H3 K18/K23 acetylations Results of targeted proteomics assays have been validated by Western blot (WB) analysis. As compared with LC-MS/MS-TMT (tandem-mass-tagging) and WB methods, the targeted proteomics method has shown higher throughput, and therefore promised to be more suitable for clinical applications. With this methodology, we find that histone acetylation is significantly lower in AD temporal lobe than found in aged controls. Targeted proteomics warrants increased application for studying epigenetics of neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)1261-1268
Number of pages8
JournalProteomics
Volume12
Issue number8
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Acetylation
Proteomics
Histones
Alzheimer Disease
Biomarkers
Epigenomics
Western Blotting
Neurodegenerative diseases
Chromatin Assembly and Disassembly
Monitoring
Memory Disorders
Biological systems
Temporal Lobe
Transcription
Neurodegenerative Diseases
Chromatin
Assays
Brain
Proteins
Genes

Keywords

  • Alzheimer's disease
  • Epigenetics
  • Histone acetylation
  • PTMs
  • Targeted proteomics
  • Technology

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

Zhang, K., Schrag, M., Crofton, A., Trivedi, R., Vinters, H., & Kirsch, W. (2012). Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. Proteomics, 12(8), 1261-1268. https://doi.org/10.1002/pmic.201200010

Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. / Zhang, Kangling; Schrag, Matthew; Crofton, Andrew; Trivedi, Rishi; Vinters, Harry; Kirsch, Wolff.

In: Proteomics, Vol. 12, No. 8, 04.2012, p. 1261-1268.

Research output: Contribution to journalArticle

Zhang, K, Schrag, M, Crofton, A, Trivedi, R, Vinters, H & Kirsch, W 2012, 'Targeted proteomics for quantification of histone acetylation in Alzheimer's disease', Proteomics, vol. 12, no. 8, pp. 1261-1268. https://doi.org/10.1002/pmic.201200010
Zhang, Kangling ; Schrag, Matthew ; Crofton, Andrew ; Trivedi, Rishi ; Vinters, Harry ; Kirsch, Wolff. / Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. In: Proteomics. 2012 ; Vol. 12, No. 8. pp. 1261-1268.
@article{6233fc1e6a29412580af425648174192,
title = "Targeted proteomics for quantification of histone acetylation in Alzheimer's disease",
abstract = "The epigenetic remodeling of chromatin histone proteins by acetylation has been the subject of recent investigations searching for biomarkers indicative of late onset cognitive loss. Histone acetylations affect the regulation of gene transcription, and the loss of learning induced deacetylation at specific histone sites may represent biomarkers for memory loss and Alzheimer's disease (AD). Selected-reaction-monitoring (SRM) has recently been advanced to quantitate peptides and proteins in complex biological systems. In this paper, we provide evidence that SRM-based targeted proteomics can reliably quantify specific histone acetylations in both AD and control brain by identifying the patterns of H3 K18/K23 acetylations Results of targeted proteomics assays have been validated by Western blot (WB) analysis. As compared with LC-MS/MS-TMT (tandem-mass-tagging) and WB methods, the targeted proteomics method has shown higher throughput, and therefore promised to be more suitable for clinical applications. With this methodology, we find that histone acetylation is significantly lower in AD temporal lobe than found in aged controls. Targeted proteomics warrants increased application for studying epigenetics of neurodegenerative diseases.",
keywords = "Alzheimer's disease, Epigenetics, Histone acetylation, PTMs, Targeted proteomics, Technology",
author = "Kangling Zhang and Matthew Schrag and Andrew Crofton and Rishi Trivedi and Harry Vinters and Wolff Kirsch",
year = "2012",
month = "4",
doi = "10.1002/pmic.201200010",
language = "English (US)",
volume = "12",
pages = "1261--1268",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "8",

}

TY - JOUR

T1 - Targeted proteomics for quantification of histone acetylation in Alzheimer's disease

AU - Zhang, Kangling

AU - Schrag, Matthew

AU - Crofton, Andrew

AU - Trivedi, Rishi

AU - Vinters, Harry

AU - Kirsch, Wolff

PY - 2012/4

Y1 - 2012/4

N2 - The epigenetic remodeling of chromatin histone proteins by acetylation has been the subject of recent investigations searching for biomarkers indicative of late onset cognitive loss. Histone acetylations affect the regulation of gene transcription, and the loss of learning induced deacetylation at specific histone sites may represent biomarkers for memory loss and Alzheimer's disease (AD). Selected-reaction-monitoring (SRM) has recently been advanced to quantitate peptides and proteins in complex biological systems. In this paper, we provide evidence that SRM-based targeted proteomics can reliably quantify specific histone acetylations in both AD and control brain by identifying the patterns of H3 K18/K23 acetylations Results of targeted proteomics assays have been validated by Western blot (WB) analysis. As compared with LC-MS/MS-TMT (tandem-mass-tagging) and WB methods, the targeted proteomics method has shown higher throughput, and therefore promised to be more suitable for clinical applications. With this methodology, we find that histone acetylation is significantly lower in AD temporal lobe than found in aged controls. Targeted proteomics warrants increased application for studying epigenetics of neurodegenerative diseases.

AB - The epigenetic remodeling of chromatin histone proteins by acetylation has been the subject of recent investigations searching for biomarkers indicative of late onset cognitive loss. Histone acetylations affect the regulation of gene transcription, and the loss of learning induced deacetylation at specific histone sites may represent biomarkers for memory loss and Alzheimer's disease (AD). Selected-reaction-monitoring (SRM) has recently been advanced to quantitate peptides and proteins in complex biological systems. In this paper, we provide evidence that SRM-based targeted proteomics can reliably quantify specific histone acetylations in both AD and control brain by identifying the patterns of H3 K18/K23 acetylations Results of targeted proteomics assays have been validated by Western blot (WB) analysis. As compared with LC-MS/MS-TMT (tandem-mass-tagging) and WB methods, the targeted proteomics method has shown higher throughput, and therefore promised to be more suitable for clinical applications. With this methodology, we find that histone acetylation is significantly lower in AD temporal lobe than found in aged controls. Targeted proteomics warrants increased application for studying epigenetics of neurodegenerative diseases.

KW - Alzheimer's disease

KW - Epigenetics

KW - Histone acetylation

KW - PTMs

KW - Targeted proteomics

KW - Technology

UR - http://www.scopus.com/inward/record.url?scp=84860863375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860863375&partnerID=8YFLogxK

U2 - 10.1002/pmic.201200010

DO - 10.1002/pmic.201200010

M3 - Article

VL - 12

SP - 1261

EP - 1268

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 8

ER -